TipRanks
KUKJE PHARMA Co., Ltd. (KR:002720)
:002720
South Korea Market
002720
KUKJE PHARMA Co., Ltd.
RESEARCH TOOLSreports

KUKJE PHARMA Co., Ltd. (002720) Ratios

― Followers

KUKJE PHARMA Co., Ltd. Ratios

KR:002720's free cash flow for Q2 2026 was ₩0.55. For the 2026 fiscal year, KR:002720's free cash flow was decreased by ₩ and operating cash flow was ₩0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.14 1.09 2.00 0.92 1.01
Quick Ratio
 0.74 0.67 1.21 0.57 0.55
Cash Ratio
 0.23 0.17 0.30 0.18 0.12
Solvency Ratio
 0.10 0.10 0.11 -0.05 0.13
Operating Cash Flow Ratio
 0.11 0.09 0.14 0.06 0.14
Short-Term Operating Cash Flow Coverage
 0.22 0.19 1.97 0.12 0.24
Net Current Asset Value
₩ -13.33B₩ -25.45B₩ -19.03B₩ -23.19B₩ -13.98B
Leverage Ratios
Debt-to-Assets Ratio
 0.17 0.16 0.18 0.19 0.21
Debt-to-Equity Ratio
 0.32 0.31 0.33 0.36 0.39
Debt-to-Capital Ratio
 0.24 0.24 0.25 0.27 0.28
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.23 0.00 0.00
Financial Leverage Ratio
 1.86 1.95 1.85 1.92 1.84
Debt Service Coverage Ratio
 0.25 0.28 3.00 -0.09 0.32
Interest Coverage Ratio
 5.58 6.81 5.56 -1.38 5.27
Debt to Market Cap
 0.44 0.34 0.28 0.25 0.25
Interest Debt Per Share
 1.52K 1.54K 1.51K 1.59K 1.46K
Net Debt to EBITDA
 1.92 2.09 1.89 -19.36 2.25
Profitability Margins
Gross Profit Margin
53.46%52.98%52.72%49.66%49.97%
EBIT Margin
2.87%3.52%4.99%-3.87%4.54%
EBITDA Margin
4.73%5.36%7.04%-0.77%8.08%
Operating Profit Margin
2.47%3.52%4.28%-1.47%4.17%
Pretax Profit Margin
3.13%3.67%4.22%-4.93%3.75%
Net Profit Margin
2.76%3.25%3.33%-6.22%2.81%
Continuous Operations Profit Margin
2.75%3.25%3.33%-6.22%2.80%
Net Income Per EBT
88.04%88.43%78.76%125.96%74.97%
EBT Per EBIT
126.94%104.18%98.62%335.85%90.00%
Return on Assets (ROA)
2.70%2.99%3.14%-5.15%2.60%
Return on Equity (ROE)
5.12%5.83%5.81%-9.91%4.80%
Return on Capital Employed (ROCE)
3.68%4.82%4.89%-1.92%5.94%
Return on Invested Capital (ROIC)
2.59%3.45%3.79%-1.49%3.39%
Return on Tangible Assets
2.72%3.01%3.16%-5.18%2.63%
Earnings Yield
7.21%6.50%5.05%-7.09%3.35%
Efficiency Ratios
Receivables Turnover
 5.85 5.88 6.35 6.63 6.22
Payables Turnover
 6.08 5.21 6.69 7.96 8.96
Inventory Turnover
 3.31 3.19 3.31 3.21 2.85
Fixed Asset Turnover
 1.82 1.78 1.59 1.37 1.61
Asset Turnover
 0.98 0.92 0.95 0.83 0.93
Working Capital Turnover Ratio
 25.27 10.41 13.12 -69.34 -44.90
Cash Conversion Cycle
 112.70 106.37 113.30 122.99 146.12
Days of Sales Outstanding
 62.40 62.07 57.52 55.08 58.70
Days of Inventory Outstanding
 110.37 114.33 110.38 113.78 128.15
Days of Payables Outstanding
 60.08 70.03 54.60 45.87 40.74
Operating Cycle
 172.78 176.40 167.90 168.86 186.86
Cash Flow Ratios
Operating Cash Flow Per Share
 316.21 286.27 193.50 176.52 321.01
Free Cash Flow Per Share
 109.87 108.73 46.42 124.88 257.99
CapEx Per Share
 206.35 177.54 147.08 51.64 63.02
Free Cash Flow to Operating Cash Flow
 0.35 0.38 0.24 0.71 0.80
Dividend Paid and CapEx Coverage Ratio
 1.34 1.38 1.32 3.42 5.09
Capital Expenditure Coverage Ratio
 1.53 1.61 1.32 3.42 5.09
Operating Cash Flow Coverage Ratio
 0.21 0.19 0.13 0.12 0.23
Operating Cash Flow to Sales Ratio
 0.04 0.03 0.03 0.03 0.05
Free Cash Flow Yield
3.35%2.53%0.92%2.13%4.93%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 13.67 15.38 19.79 -14.10 29.83
Price-to-Sales (P/S) Ratio
 0.38 0.50 0.66 0.88 0.84
Price-to-Book (P/B) Ratio
 0.70 0.90 1.15 1.40 1.43
Price-to-Free Cash Flow (P/FCF) Ratio
 29.85 39.55 109.00 46.92 20.30
Price-to-Operating Cash Flow Ratio
 10.37 15.02 26.15 33.20 16.32
Price-to-Earnings Growth (PEG) Ratio
 -0.58 1.65 -0.12 0.04 -0.09
Price-to-Fair Value
 0.70 0.90 1.15 1.40 1.43
Enterprise Value Multiple
 10.02 11.41 11.24 -133.86 12.62
Enterprise Value
 85.89B 107.35B 123.86B 138.76B 129.18B
EV to EBITDA
 10.02 11.41 11.24 -133.86 12.62
EV to Sales
 0.47 0.61 0.79 1.03 1.02
EV to Free Cash Flow
 36.94 48.44 131.04 54.86 24.71
EV to Operating Cash Flow
 12.84 18.40 31.44 38.81 19.86
Tangible Book Value Per Share
 4.63K 4.72K 4.36K 4.15K 3.60K
Shareholders’ Equity Per Share
 4.70K 4.79K 4.40K 4.19K 3.66K
Tax and Other Ratios
Effective Tax Rate
 0.12 0.11 0.21 -0.26 0.25
Revenue Per Share
 8.57K 8.61K 7.68K 6.68K 6.25K
Net Income Per Share
 236.35 279.51 255.64 -415.49 175.58
Tax Burden
 0.88 0.88 0.79 1.26 0.75
Interest Burden
 1.09 1.04 0.85 1.27 0.83
Research & Development to Revenue
 0.04 0.04 0.01 0.04 0.02
SG&A to Revenue
 0.43 0.39 0.37 0.32 0.22
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.34 1.02 0.76 -0.42 1.84
Currency in KRW